NZSE:ATMFood
Is a2 Milk (NZSE:ATM) Still Undervalued After The FDA Infant Formula Recall?
FDA enforcement report and US infant formula recall
a2 Milk (NZSE:ATM) is in focus after the US Food and Drug Administration issued an enforcement report related to the company’s voluntary Class I recall of a2 Platinum Premium Infant Formula distributed across the United States.
See our latest analysis for a2 Milk.
The FDA enforcement report comes after a strong short term rebound in a2 Milk’s share price, with a 30 day share price return of 28.70% and a 7 day return of 8.38%. The stock...